The effects of an orally administered cholinergic agonist on REM sleep in major depression

Biological Psychiatry

Volumn 51, Issue 6, 2002, Pages 457-462

  Perlis, Michael L ^a   Smith, Michael T ^a   Orff, Henry J ^a   Andrews, Patrick J ^a   Gillin, J Christian ^b   Giles, Donna E ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aricept; Cholinergic agonist; Depression; Donepezil; REM sleep

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT; DONEPEZIL;

ADULT; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG RESPONSE; FEMALE; HUMAN; LATENT PERIOD; MALE; PRIORITY JOURNAL; REM SLEEP;

ADMINISTRATION, ORAL; ADULT; CHOLINERGIC AGENTS; CHOLINESTERASE INHIBITORS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INDANS; MALE; MIDDLE AGED; PIPERIDINES; POLYSOMNOGRAPHY; REACTION TIME; SINGLE-BLIND METHOD; SLEEP, REM;

EID: 0037087349     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01287-2     Document Type: Article

References (41)

1. The family history method using diagnostic criteria: Reliability and validity
2. Cholinergic mechanisms regulating REM sleep
3. Location and quantification of muscarinic receptor subtypes in rat pons: Implications for REM sleep generation
4. The evoked K-complex: All-or-none phenomenon?
5. Psychometric properties of the Beck Depression Inventory, twenty-five years of evaluation
6. Sleep and psychiatric disorders: A meta-analysis
7. Sleep and mood disorders
8. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research
9. Cyclic variations in EEG during sleep and their relation to eye movements, body motility and dreaming
10. Pharmacologic induction of cholinergic system up-regulation and supersensitivity in affective disorders research
11. A diagnostic interview: The scedule for affective disorders and schizophrenia
12. Nosology of primary affective disorders and application to clinical research
13. Diagnostic criteria for use in psychiatric research
14. The adrenergic-cholinergic imbalance hypothesis of depression: A review and a perspective
15. Risk factors in families of unipolar depression: I. Psychiatric illness and reduced REM latency
16. Risk factors in unipolar depression II: Relation between proband REM latency and cognitions of relatives
17. Controlled comparison of electrophysiological sleep in families of probands with unipolar depression
18. REM latency concordance in depressed family members
19. Muscarinic supersensitivity: A possible model for the sleep disturbance of primary depression?
20. Physostigmine alters onset but not duration of REM sleep in man
21. The cholinergic rapid eye movement induction test with arecoline in depression
22. A rating scale for depression
23. REM sleep and cortisol response to the cholinergic challenge with RS 86 in normals and depressives
24. The influence of the muscarinic agonist RS 86 on the cortisol system
25. Supersensitivity to light: Possible trait marker for manic-depressive illness
26. Measuring cholinergic sensitivity: I. Arecoline effects in bipolar patients
27. EEG sleep in depression and in remission and the REM sleep response to the cholinergic agonist RS 86
28. Sleep, age, depression and the cholinergic REM induction test with RS 86
29. Effect of RS 86 on REM latency in schizophrenia
30. Sleep in depression: The influence of age, gender and diagnostic subtype on baseline sleep and the cholinergic REM induction test with RS 86
31. The cholinergic REM induction test with RS 86 after scopolamine pretreatment in healthy subjects
32. Influence of the cholinergic agonist RS 86 on normal sleep: Sex and age effects
33. Brainstem mechanisms generating REM sleep
34. REM sleep induction by physostigmine infusion during sleep
35. The time-dependent induction of REM sleep and arousal by physostigmine infusion during normal human sleep
36. Induction and resetting of REM sleep rhythm in normal man by arecholine: Blockade by scopolamine
37. Effects of RS 86, an orally active cholinergic agonist, on sleep in man
38. The Structured Clinical Interview for OSM-IIIR (SCID): I. History, Rationale and Description